<DOC>
	<DOC>NCT00626535</DOC>
	<brief_summary>This study compares 4 weeks of treatment with Esomeprazole 20 mg once daily to Placebo in the treatment of Upper Abdominal Pain in patients with Symptomatic Gastroesophageal Reflux Disease (sGERD)</brief_summary>
	<brief_title>A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>History of episodes of heartburn and upper abdominal pain for 6 months or longer. Episodes of heartburn 2 or more days during the 7 days prior to the screening visit. Moderate or severe upper abdominal pain on at least 3 out of the 7 consecutive days of the runin period. A normal endoscopy within 14 days of Visit 1 of between Runin and randomization. Subjects with pain likely to be due to irritable bowel syndrome (IBS) History of esophageal, gastric or duodenal surgery, except for closure of an ulcer. History of severe liver disease, including (but not limited to) cirrhosis and acute or chronic hepatitis. Further diseases / conditions, as listed in the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Symptomatic Gastroesophageal Reflux Disease (sGERD)</keyword>
	<keyword>Nexium</keyword>
	<keyword>Esomeprazole</keyword>
</DOC>